South African egg prices seen rising 20 percent after avian flu outbreak

JOHANNESBURG (Reuters) – Egg prices in South Africa are expected to increase by as much as 20 percent after an outbreak of the highly pathogenic avian flu in June forced farmers to cull egg laying birds, industry experts said on Thursday.

The outbreak of avian flu prompted farmers to cull millions of birds and neighboring countries including Zimbabwe, Namibia and Botswana to ban poultry imports from South Africa.

Industry experts said in October commercial egg production had tumbled 17 percent and over 1,000 workers lost their jobs in the wake of the outbreak of avian flu.

Prices are expected to increase between 15 and 20 percent from December to June 2018, said Senior Agricultural Economist at FNB Business, Paul Makube.

“The increase in egg prices is subject to demand and supply dynamics with the Influenza outbreak having a major influence on the recent spike,” said Makube.

The laying flock of 20.8 million hens had decreased 14.6 percent in October compared with the same period last year, while egg production during October 2017 decreased by 15.7 percent compared to October 2016, data from the South African Poultry Association showed.

Makube said shortages were expected to last up to a year.

However the price increase and the lower maize prices following a bumper 2017 season are expected to help the industry improve profitability after being hit with a severe drought in 2015 that led to job cuts and high feed prices.

“The upside is that the price increase will help producers to recoup losses as they are still servicing debt incurred during the last drought,” said Makube.

South Africa’s maize prices have remained low following the biggest crop on record forecast at 16.744 million tonnes by the Crop Estimates Committee.

Editing by James Macharia and Elaine Hardcastle

Our Standards:The Thomson Reuters Trust Principles.
No Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

health
Bumper crop of new drugs fails to lift big pharma R&D returns

LONDON (Reuters) – It is shaping up to be a bumper year for drug approvals, with U.S. officials clearing twice as many novel medicines as in 2016, yet returns on research investment at leading pharmaceutical companies are down. FILE PHOTO – A view shows the U.S. Food and Drug Administration …

health
Ohio passes law barring abortion over Down syndrome diagnosis

CLEVELAND (Reuters) – Women in Ohio would be prohibited from receiving abortions because of a fetal Down syndrome diagnosis under a bill that passed the state senate on Wednesday and is heading to Republican Governor John Kasich’s desk. FILE PHOTO: Ohio Governor John Kasich speaks during news conference in Columbus, …

health
U.S. study sheds light on how Zika causes nerve disorder

CHICAGO (Reuters) – A new study sheds light on how the mosquito-borne Zika virus causes a rare neurological condition, and the findings could have implications for companies working on Zika vaccines, U.S. researchers said on Wednesday. FILE PHOTO: An aedes aegypti mosquito is pictured on a leaf in San Jose, …